Form 8-K - Current report:
SEC Accession No. 0001437749-25-012540
Filing Date
2025-04-21
Accepted
2025-04-21 16:37:46
Documents
18
Period of Report
2025-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sava20250418_8k.htm   iXBRL 8-K 40590
2 EXHIBIT 10.2 ex_803688.htm EX-10.2 55554
3 EXHIBIT 10.3 ex_803689.htm EX-10.3 56903
4 EXHIBIT 99.1 ex_804586.htm EX-99.1 15673
9 prlogo.jpg GRAPHIC 13204
  Complete submission text file 0001437749-25-012540.txt   366885

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sava-20250415.xsd EX-101.SCH 3579
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sava-20250415_def.xml EX-101.DEF 11807
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE sava-20250415_lab.xml EX-101.LAB 15858
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sava-20250415_pre.xml EX-101.PRE 12022
20 EXTRACTED XBRL INSTANCE DOCUMENT sava20250418_8k_htm.xml XML 2968
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41905 | Film No.: 25853830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)